Bowmann-Birk Inhibitor Concentrate (BBIC) is a natural soy-based substance. A US based study finds: BBIC improves the condition of animals with a disease similar to multiple sclerosis.
A group of animals with Autoimmune Encephalomyelitis (EAE) received BBIC, while another group of animals also suffering from the same disease received a placebo.
'Animals that received BBIC were able to walk, while those that didn't get the drug were not,' said the study leader Dr. A.M. Rostami, professor and chairperson of the department of Neurology at Jefferson Medical College in Philadelphia.
The animals that received BBIC were able to walk though with some limp or weakness. Although they were'nt completely cured, the results are promising, the researchers said.
It was also found that the CNS of the animals that received BBIC had 'significantly less inflammation and demyelination' than animals that hadn't received BBIC.
'It's the first time that BBIC has been used in an EAE model and has shown significant disease suppression, and we hope it can eventually be used in humans,' Rostami said.
BBIC inhibits secretion of Proteases, a group of enzymes that are responsible for the inflammation and demyelination associated with multiple sclerosis (MS), a condition which causes inflammation in the myelin coating of nerve fibers.